FindTrial
Sign In

Prevention of hyperalgesia after remifentanyl infusion by fentanyl,sufentanyl and paracoxib

A single center prospective trial of preventing the hyperalgesia after remifentanyl infusion

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-12002446
Enrollment
Unknown
Registered
2012-08-19
Start date
2012-08-19
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hyperalgesia after remifentanyl infusion

Interventions

FEN1:fentanyl 1ug/kg
SUF:sufentanyl
PAR1:paracoxib 40mg
FEN2:fentanyl 2ug/kg
PAR2:paracoxib 80mg

Sponsors

department of anesthesiology, Xijing hospital
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
30 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1. Gynecological laparoscopic operation; 2. ASA 1-2; 3. BMI 18-25.

Exclusion criteria

Exclusion criteria: 1. Duration of surgery longer than 2h; 2. Abnormal liver or renal function; 3. HCG test positive; 4. Drug abuse; 5. Difficult to understand VAS scoring.

Design outcomes

Primary

MeasureTime frame
VAS score;OAAS score;satisfaction score on pain control;remedy;—

Secondary

MeasureTime frame
PONV score;time to awake;time to extubation;time to orientation;—

Contacts

Public ContactZhihong-LU
deerlufmmu@hotmail.com+86 13891975018

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026